3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
HIV Infections
1
Anemia, Sickle Cell
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
fludarabine
3
Specimen Handling
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Eflornithine
2
Cisplatin
2
tazemetostat
1
talazoparib
1
selinexor
1
pazopanib
1
palbociclib
1
mifamurtide
1
merphos
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Bortezomib
×
30 days
×
Clear all
No trials found.